The incoming Biden health team is a mix of newcomers to the executive branch and former Obama administration officials. We discuss the nominees and offer our insights and recommendations for success, particularly in regards to the ongoing COVID-19 response. 

With COVID-19 cases on the rise, what should we expect in the coming weeks as the first vaccines in the U.S. are approved and distribution begins? We discuss the latest news and why it's so difficult to listen and adhere to the advice of our nation's public health experts. 

With the recent good news about the Pfizer and Moderna Phase 3 trials exhibiting greater than 90% efficacy, what exactly does this mean and how does it compare to other vaccines? In this episode, we discuss the impact of these results and the next steps in the vaccine distribution process.

The fight for the majority in the US Senate hinges on two Georgia Senate races. Regardless of who holds the majority, however, big changes are ahead as a number of key committees with jurisdiction over the nation's public health agencies are likely to change leadership and greatly impact the future of the COVID-19 response.